- EXP Pharmaceutical Services, a leader in the pharmaceutical reverse logistics industry, today announced the successful completion of its first Statement on Standards for Attestation Engagements (SSAE) No. 16. The audit confirmed EXP to be successful in all areas of the company's design and operating effectiveness of internal controls and processes.
“At EXP, our entire team is dedicated to preserving the security of our customers’ data with the highest internal operational controls the industry allows,” said Nadine You, president of EXP Pharmaceutical Services. “These rigorous audits represent the investments in our controls and customers, as well as our reputation as a preferred vendor,” said Gus Changaris, EXP’s CEO.
Completion of the SSAE-16 attestation expands the prospective client base of EXP for organizations required to meet the highest security, operational and technological standards. The audit was conducted by Armanino McKenna LLP, a full-service accounting firm specializing in SSAE-16 Type I and Type II audits.
For more information about EXP Pharmaceutical Services, visit: www.expworld.com.
About EXP Pharmaceutical Services Corp.
EXP Pharmaceutical Services is a leader in the pharmaceutical reverse distribution industry, specializing in expired pharmaceutical product returns processing, professional waste disposal and customized reporting services. EXP serves hospital, government, independent retail, chain-store, clinic, long-term care, veterinarian and additional pharmacy segments including wholesalers and manufacturers.
EXP is the only pharmaceutical reverse distributor to have created a growing, nationwide network of more than 80 service and management field offices based in most states and serving all 50 states, U.S. properties and international locations around the world.